MeSH D004927 - escherichia coli infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ceftriaxone | Ceftriaxone |  | 2007-03-15 |  |  |
| Levofloxacin | Levofloxacin |  | 2011-06-20 |  |  | |
| Ofloxacin | Ofloxacin |  | 2003-09-02 |  |  | |
| Glenmark Pharmaceuticals | Levofloxacin | Levofloxacin |  | 2011-06-20 |  |  |
| Mylan | Levofloxacin | Levofloxacin |  | 2011-06-20 |  |  |
| Johnson & Johnson | Levofloxacin | Levaquin |  | 1996-12-20 |  |  |
| Ofloxacin | Floxin |  | 1990-12-28 |  |  |
1
2
3
4
5
6
...
18
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/2
Phase 2
100%2/2
Phase 3
99%76/77
Approved: 75Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use